Characterization of a novel class A carbapenemase PAD-1 from Paramesorhizobium desertii A-3-ET, a strain highly resistant to β-lactam antibiotics
Abstract Although clinical antibiotic-resistant bacteria have attracted tremendous attention in the microbiology community, the resistant bacteria that persist in natural environments have been overlooked for a longtime. We previously proposed a new species Paramesorhizobium desertii, isolated from...
Guardado en:
Autores principales: | Ruichen Lv, Jingyu Guo, YanFeng Yan, Rong Chen, Lisheng Xiao, Min Wang, Nan Fang, Chengxiang Fang, Yujun Cui, Ruifu Yang, Yajun Song |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/13aac20497174f87aa96edd8e2638fa2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Quantitative Insights Into β-Lactamase Inhibitor’s Contribution in the Treatment of Carbapenemase-Producing Organisms With β-Lactams
por: Yanfang Feng, et al.
Publicado: (2021) -
Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance.
por: Victor I Band, et al.
Publicado: (2021) -
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
por: R. Bruch, et al.
Publicado: (2017) -
Reversible inactivation of a peptidoglycan transpeptidase by a β-lactam antibiotic mediated by β-lactam-ring recyclization in the enzyme active site
por: Zainab Edoo, et al.
Publicado: (2017) -
A Natural Deep Eutectic Solvent Formulated to Stabilize β-Lactam Antibiotics
por: Belén Olivares, et al.
Publicado: (2018)